Managing IgAV: Treatment Strategies and Guidelines
At a Glance
Most cases of Immunoglobulin A Vasculitis (IgAV) resolve on their own with rest and hydration. Treatment depends on severity: mild cases use acetaminophen, while moderate to severe cases may require corticosteroids or immunosuppressants to manage abdominal pain and protect the kidneys. You should strictly avoid NSAIDs like ibuprofen unless prescribed.
Deciding on a treatment path for Immunoglobulin A Vasculitis (IgAV) requires balancing the need to control painful symptoms with the goal of protecting long-term organ health, particularly the kidneys. Doctors often look to the SHARE guidelines—a set of international expert recommendations—to ensure patients receive consistent, evidence-based care [1].
The Foundation of Care: Supportive Management
For most children and many adults, IgAV follows a “self-limiting” path, meaning it will resolve on its own with rest and time [2].
- Rest and Hydration: Standard care for mild cases involves managing pain and ensuring the patient stays hydrated, especially if abdominal pain makes eating difficult.
- The NSAID Warning: You should strictly avoid Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen (Advil/Motrin) or naproxen (Aleve) unless they are explicitly prescribed and monitored by your doctor [3]. These medications can irritate the stomach lining and put extra stress on the kidneys—two areas already under attack in IgAV—increasing the risk of gastrointestinal bleeding or kidney injury [3][4].
- Safe Alternatives: For over-the-counter pain relief, acetaminophen (Tylenol) is generally preferred and considered safe, as it does not carry the same bleeding or kidney risks [5]. (Note: Always confirm with your physician before starting any medication).
Treatment Decision Tree
Doctors stratify treatment based on which systems are involved and the severity of the inflammation [6]. Both Rheumatologists (experts in systemic inflammation) and Nephrologists (kidney experts) frequently collaborate on these decisions.
| Severity Level | Clinical Findings | Typical Treatment Strategy |
|---|---|---|
| Mild | Skin rash and mild joint pain only. | Supportive care; rest and acetaminophen for pain relief [1]. |
| Moderate (GI) | Severe abdominal pain that interferes with eating/sleeping. | Short-term corticosteroids (typically 1 to 2 weeks, sometimes with a tapering period) to quickly reduce gut inflammation [7][8]. |
| Moderate (Renal) | Significant protein or blood in the urine (nephritis). | Oral steroids and potentially ACE inhibitors (blood pressure meds) to protect kidney filters [6][9]. |
| Severe | Kidney failure or life-threatening GI bleeding. | High-dose “pulsed” IV steroids and strong immunosuppressants like Cyclophosphamide or Mycophenolate Mofetil (MMF) [6][10]. |
The Role of Steroids
Corticosteroids (like prednisolone) are powerful anti-inflammatory drugs, but they are not used for every case of IgAV.
- For Abdominal Pain: Steroids can significantly reduce the duration and intensity of gut pain. Doctors aim to use them for the shortest time possible (often 1 to 2 weeks) to provide relief while minimizing the side effects of long-term steroid use [7].
- For Kidney Protection: While steroids are used to treat active kidney inflammation, research has shown that taking steroids early does not prevent kidney disease from developing later [11][12]. This is why doctors wait for signs of kidney stress in the urine before starting them.
Advanced Therapies for Severe Cases
If the kidneys show signs of significant damage (determined by a biopsy), more aggressive “steroid-sparing” agents may be needed.
- Mycophenolate Mofetil (MMF): Often used for persistent or relapsing kidney inflammation, MMF helps calm the immune system’s attack on the kidneys with fewer long-term side effects than older drugs [10].
- Cyclophosphamide: Reserved for the most severe cases of nephritis (kidney inflammation) to prevent progression to permanent kidney failure [6].
Adult Management Nuances
Because adults are at a much higher risk for permanent kidney damage, their treatment is often more aggressive from the start [13]. Adult patients are heavily encouraged to build a care team that includes a Rheumatologist and a Nephrologist to manage immunosuppression safely and achieve long-term remission [14][15].
To learn what happens after the acute treatment phase ends, proceed to The Road to Recovery: Renal Monitoring and Long-Term Health.
Common questions in this guide
Why shouldn't I take ibuprofen or naproxen for IgAV pain?
Will taking steroids early prevent kidney damage from IgAV?
How long will I need to take steroids for abdominal pain?
How are severe cases of IgAV treated?
Is IgAV treated differently in adults compared to children?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my (or my child's) case qualify as 'mild,' 'moderate,' or 'severe' based on the SHARE consensus definitions?
- 2.If we are using steroids, what is the planned duration and weaning schedule?
- 3.What over-the-counter pain medications are safe for me (or my child) to take right now for joint pain?
- 4.Should we be consulting a Rheumatologist to help manage the systemic inflammation?
- 5.If the urine protein remains high, at what point do we need to consult a nephrologist for advanced immunosuppressants like MMF?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.
Ozen S, Marks SD, Brogan P, et al.
Rheumatology (Oxford, England) 2019; (58(9)):1607-1616 doi:10.1093/rheumatology/kez041.
PMID: 30879080 - 2
Comparing immunoglobulin A vasculitis (Henoch-Schönlein purpura) in children and adults: a single-centre study from Turkey.
Batu ED, Sarı A, Erden A, et al.
Scandinavian journal of rheumatology 2018; (47(6)):481-486 doi:10.1080/03009742.2018.1448111.
PMID: 29912602 - 3
Acute Esophageal Necrosis Presenting With Henoch-Schönlein Purpura.
Iorio N, Bernstein GR, Malik Z, Schey R
ACG case reports journal 2015; (3(1)):17-9 doi:10.14309/crj.2015.87.
PMID: 26504868 - 4
IgA Vasculitis in Adults: a Rare yet Challenging Disease.
Yaseen K, Herlitz LC, Villa-Forte A
Current rheumatology reports 2021; (23(7)):50 doi:10.1007/s11926-021-01013-x.
PMID: 34196893 - 5
Non-opioid Analgesics and the Endocannabinoid System
Topuz RD, Gündüz Ö, Karadağ ÇH, Ulugöl A
Balkan medical journal 2020; (37(6)):309-315 doi:10.4274/balkanmedj.galenos.2020.2020.6.66.
PMID: 32551466 - 6
Diagnostic and Management Strategies of IgA Vasculitis Nephritis/Henoch-Schönlein Purpura Nephritis in Pediatric Patients: Current Perspectives.
Sestan M, Jelusic M
Pediatric health, medicine and therapeutics 2023; (14()):89-98 doi:10.2147/PHMT.S379862.
PMID: 36915829 - 7
Early discontinuation of steroid treatment in children with abdominal pain due to IgA vasculitis.
Kambara S, Nishio N, Sugiyama Y, et al.
European journal of pediatrics 2025; (184(5)):279 doi:10.1007/s00431-025-06107-7.
PMID: 40183803 - 8
Acute pancreatitis associated with immunoglobulin A vasculitis: report of fifteen cases.
Du L, Liu C, Wang X, et al.
Clinical rheumatology 2023; (42(3)):839-847 doi:10.1007/s10067-022-06398-3.
PMID: 36197648 - 9
Childhood IgA Vasculitis (Henoch Schonlein Purpura)-Advances and Knowledge Gaps.
Oni L, Sampath S
Frontiers in pediatrics 2019; (7()):257 doi:10.3389/fped.2019.00257.
PMID: 31316952 - 10
Gastrointestinal Henoch-Schönlein purpura successfully treated with Mycophenolate Mofetil: Description of 2 case reports.
Gicchino MF, Iafusco D, Marrapodi MM, et al.
Medicine 2021; (100(1)):e24093 doi:10.1097/MD.0000000000024093.
PMID: 33429774 - 11
Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).
Hahn D, Hodson EM, Willis NS, Craig JC
The Cochrane database of systematic reviews 2015; CD005128 doi:10.1002/14651858.CD005128.pub3.
PMID: 26258874 - 12
Steroid-Dependent Recurrent IgA Vasculitis in a 19-Year-Old Woman.
Berrett H, Gohil S, Kurian R, Neyman P
HCA healthcare journal of medicine 2024; (5(4)):453-458 doi:10.36518/2689-0216.1660.
PMID: 39290479 - 13
Clinical Characteristics of Biopsy-Proven IgA Vasculitis in Children and Adults: A Retrospective Cohort Study.
Villatoro-Villar M, Crowson CS, Warrington KJ, et al.
Mayo Clinic proceedings 2019; (94(9)):1769-1780 doi:10.1016/j.mayocp.2019.04.034.
PMID: 31486380 - 14
An Unusual Case of Bilateral Lower Extremity Edema in the Elderly: Immunoglobulin A (IgA) Vasculitis.
Yanagihara T, Nakagawa T, Nishie H, et al.
Cureus 2023; (15(7)):e42684 doi:10.7759/cureus.42684.
PMID: 37529819 - 15
Adult Henoch-Schönlein purpura: Clinical and histopathological predictors of systemic disease and profound renal disease.
Cao R, Lau S, Tan V, Tey HL
Indian journal of dermatology, venereology and leprology 2017; (83(5)):577-582 doi:10.4103/ijdvl.IJDVL_571_16.
PMID: 28485308
This page provides educational information on IgAV treatment strategies and guidelines. It does not replace professional medical advice. Always consult your rheumatologist or nephrologist regarding your specific care plan and medication safety.
Get notified when new evidence is published on Immunoglobulin A vasculitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.